Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Nava Health vs Tablet Health

Nava Health
Graded #320

Higher grade

vs+13
Tablet Health
Graded #495

Lower grade

The verdict

Nava Health takes it — 60.6/100 to 47.6/100.

Nava Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Nava Health is a functional and integrative medicine practice offering its NavaRX medical weight loss program with GLP-1 medications (semaglutide and tirzepatide, brand or compounded).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
45
45
Dose & formulationNava Health +2
53
51
Clinical oversightNava Health +43
80
37
Labs & monitoringNava Health +23
73
50
FulfillmentNava Health +5
62
57
Contract termsEven
55
55
Nava Health · left barTablet Health · right bar

The numbers

MetricNava HealthTablet Health
WeighScore60.6/10047.6/100
GradeCC
Scorecard rank#320#495
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyYes
Nava Health

Graded #320 · C

Strengths

  • Integrative functional-medicine approach with advanced lab testing
  • Both telemedicine and in-person options
  • Board-certified MDs, DOs, NPs, PAs, and nutritionists
  • Offers both brand and compounded GLP-1 formulations
  • Financing and membership plans available

Where it loses points

  • No published GLP-1 medication pricing online
  • Consultation plus lab work adds to total cost
  • Bundled integrative model costs more than medication-only platforms
  • State availability for telehealth not clearly listed
Tablet Health

Graded #495 · C

Strengths

  • LegitScript Certified
  • Four named compounding pharmacy partners (Pharmacy Hub, Epiq Scripts, Dr. TelX, Emerad), none with FDA warning letters
  • Oral GLP-1 option for both semaglutide and tirzepatide — uncommon in compounded telehealth
  • Mid-tier pricing starting $179–$299/mo across all four product variants
  • No commitment — cancel anytime

Where it loses points

  • States served not published — you must complete the intake quiz to learn eligibility
  • No founder, CEO, medical director, or pharmacist-in-charge named anywhere
  • No BBB profile found
  • Its Queens NYC pharmacy is 'opening soon' — all dispensing currently routes through external partners
  • FDA issued this company a warning letter dated 19 March 2025; the letter is public in FDA's warning-letter database

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard